Folio
Sign inStart free

Folio Search · free preview

Papers on “vitamin D deficiency health outcomes supplementation”

Live results from Semantic Scholar, CrossRef and OpenAlex. No account needed to look.

  4. Vitamin D Deficiency and Outcome of COVID-19 Patients

    Aleksandar Radujkovic, Theresa Hippchen, Shilpa Tiwari‐Heckler, et al. · 2020 · Nutrients · 428 cites

    Infection with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) poses an enormous challenge to health care systems throughout the world. Without causal treatment, identification of modifiable prognostic factors may help to improve outcomes. To explore possible associations of vitamin D (VitD) status with disease severity and survival, we studied 185 patients diagnosed with coronavirus disease 2019 (COVID-19) and treated at our center. VitD status at first presentation was assessed retrospectively using accredited laboratory methods. VitD deficiency was defined as serum total 25-hydroxyvitamin D level < 12 ng/mL (<30 nM). Primary endpoint was severe course of disease (i.e., ne

    Save to my library →

  6. Vitamin D Deficiency is a Predictor of Reduced Survival in Patients with Heart Failure; Vitamin D Supplementation Improves Outcome

    Israel Gotsman, Ayelet Shauer, Donna R. Zwas, et al. · 2012 · European Journal of Heart Failure · 199 cites

    AIMS: Vitamin D deficiency is a highly prevalent, global phenomenon. The prevalence in heart failure (HF) patients and its effect on outcome are less clear. We evaluated vitamin D levels and vitamin D supplementation in patients with HF and its effect on mortality. METHODS AND RESULTS: 25-Hydroxyvitamin D [25(OH)D] levels were evaluated in HF patients from a health maintenance organization (HMO), and compared them with those of the rest of the members of the HMO. Patients with HF (n = 3009) had a lower median 25(OH)D level compared with the control group (n = 46 825): 36.9 nmol/L (interquartile range 23.2-55.9) vs. 40.7 nmol/L (26.7-56.9), respectively, P < 0.00001. The percentage of patient

    Save to my library →

  7. Vitamin D Metabolism and Guidelines for Vitamin D Supplementation

    Indra Ramasamy · 2020 · Clinical Biochemist Reviews · 192 cites

    Vitamin D is essential for bone health and is known to be involved in immunomodulation and cell proliferation. Vitamin D status remains a significant health issue worldwide. However, there has been no clear consensus on vitamin D deficiency and its measurement in serum, and clinical practice of vitamin D deficiency treatment remains inconsistent. The major circulating metabolite of vitamin D, 25-hydroxyvitamin D (25(OH)D), is widely used as a biomarker of vitamin D status. Other metabolic pathways are recognised as important to vitamin D function and measurement of other metabolites may become important in the future. The utility of free 25(OH)D rather than total 25(OH)D needs further assess

    Save to my library →

  8. Recognition and management of vitamin D deficiency.

    Paula Bordelon, Maria V Ghetu, Robert C Langan · 2009 · PubMed · 183 cites

    Vitamin D deficiency affects persons of all ages. Common manifestations of vitamin D deficiency are symmetric low back pain, proximal muscle weakness, muscle aches, and throbbing bone pain elicited with pressure over the sternum or tibia. A 25-hydroxyvitamin D level should be obtained in patients with suspected vitamin D deficiency. Deficiency is defined as a serum 25-hydroxyvitamin D level of less than 20 ng per mL (50 nmol per L), and insufficiency is defined as a serum 25-hydroxyvitamin D level of 20 to 30 ng per mL (50 to 75 nmol per L). The goal of treatment is to normalize vitamin D levels to relieve symptoms and decrease the risk of fractures, falls, and other adverse health outcomes.

These are the first 8. There are millions more.

A free account opens every result across all sources, plus saving to your library, one-click citations, and AI synthesis of what you found. The search itself stays free.

See all results free →

Already have an account? Sign in